Design and Synthesis of AZD3463, a Novel Orally Bioavailable Dual ALK and IGF1R Inhibitor, Inhibits Growth of Crizotinib Resistance Cell Lines with Multiple Mechanisms of Acquired Resistance.
Cancer Research（2013）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined